… judging tumor differentiation, tumor stage, and prognosis[16-17]. Therefore, non-invasive
and direct detection for P63 is important for NSCLC precision medicine for those patients who …

… years, lung cancer incidence and mortality of cancer at first, but the vast majority of patients
in the first option is already late, loses the chance of radical surgery treatment… treatment, there …

… provide possible targets for the treatment of advanced-stage non-small cell lung cancer (…
5-year survival rates of lung cancer range from 4% to 17%, depending on the cancer staging …

… Lung cancer is the leading cause of cancerrelated mortality worldwide, accounting for 26%–…
cancer deaths.(1) Approximately 85% of lung cancer is non-small cell lung cancer (NSCLC). …

… , with more than 1.5 million new cases and more than 1 million deaths a year worldwide.
About 80% of lung cancer cases are classified as non-small cell lung cancer (NSCLC), most of …

… The prognosis of a slow growing lung cancer is relatively good but rapidly growing cancer is
not… We report a very rare case that surgically treated early stage non-small cell lung cancer (…

… of patients with cancer because they not only contribute to the development of malnutrition,
but also increase morbidity and mortality … by either the cancer itself or by cancer treatment. It …

… Abstract: Lung cancer is one of the world’s most common and most malignant tumors. The
five-year survival rate of is about 17%, non-small cell lung cancer (NSCLC) accounting for …

… ’s quality of life and prolong the survival period. However, for patients with non-small cell
lung cancer, as patients are often diagnosed at an advanced stage, chemotherapy, radiotherapy…

… 非小细胞肺癌(non-small cell lung cancer, NSCLC)大约占到… a patient who had advanced
severe lung adenocarcinoma … has achieved an overall survival of at least 3.4 years with multiple-…